Global Ocular Implants Market Size study, by Product (Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Ocular Prosthesis, Others) by Application (Glaucoma Surgery, Oculoplasty, Drug Delivery, Age-related Macular Degeneration, Aesth

Global Ocular Implants Market Size study, by Product (Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Ocular Prosthesis, Others) by Application (Glaucoma Surgery, Oculoplasty, Drug Delivery, Age-related Macular Degeneration, Aesthetic Purpose) by End-use (Hospitals, Specialty Eye Institutes, Clinics) and Regional Forecasts 2022-2028

Global Ocular Implants Market is valued approximately USD 14.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2022-2028. An intraocular lens implant is a synthetic, artificial lens that is implanted inside the eye to replace the focusing power of a natural lens that has been surgically removed, most commonly during cataract surgery. The market is expected to be driven by an increase in the frequency of eye illnesses such as age-related macular degeneration, cataract, glaucoma, and scleritis. As the rate of occurrence rises, so does the demand for surgical procedures that require ocular implants. According to the United States National Library of Medicine study, based on previous trends in cataract procedures, 3.7 million cataract surgeries are expected to be done among Medicare beneficiaries in the United States in 2020. Age-related disorders include cataracts and age-related macular degeneration in the eyes. Another element driving the market's expansion is an increase in the geriatric population. Additionally, the increased incidence of diabetes and the increasing adoption of a sedentary lifestyle may lead to diabetic retinopathy, which is expected to raise ocular implant sales. According to the International Diabetes Federation, around 537 million people had diabetes in 2021, and this number is expected to climb to 643 million by 2030. Another major aspect driving market expansion is technological advancement. The emergence of micro-invasive glaucoma devices for glaucoma sufferers is a typical example of technology progress in recent years. Glaukos Corporation, for example, got FDA approval in June 2018 for its iStent Inject second-generation trabecular meshwork bypass stent. The device is approved for use during phacoemulsification and is suggested for the treatment of mild to moderate glaucoma. However, over the projection period of 2022-2028, the market's growth would be hampered by the high cost of implants.

The key regions considered for the global Ocular Implants Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America led the market. The rising frequency of eye problems, sedentary lifestyles, and key players' increased focus on launching products in North America are all contributing to the region's market expansion. A good reimbursement scenario and the availability of technologically advanced items in the region are some factors that are likely to keep the region in the lead during the projection period. During the projection period, the Asia Pacific market is predicted to grow at the fastest rate. Due to a large increase in the geriatric population, developing countries such as China and India are likely to have the highest growth in Asia Pacific. According to China's seventh population census, the country's population aged 60 and more accounted for 18.7% of the overall population in 2020. Other factors driving market expansion include an increase in the diabetic population, an increase in cataract procedures, and rising personal and government spending on eye care.

Major market player included in this report are:
Alcon, Inc.,
Bausch & Lomb, Inc.
Carl Zeiss AG
Johnson & Johnson
STAAR Surgical Company
Morcher GmbH
Hoya Corporation
Glaukos Corporation
Second Sight
Allergan

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Intraocular Lens
Corneal Implants
Orbital Implants
Glaucoma Implants
Ocular Prosthesis
Others
By Application
Glaucoma Surgery
Oculoplasty
Drug Delivery
Age-related Macular Degeneration
Aesthetic Purpose
By End-use
Hospitals
Specialty Eye Institutes
Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Ocular Implants Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Alcon, Inc.,
Bausch & Lomb, Inc.
Carl Zeiss AG
Johnson & Johnson
STAAR Surgical Company
Morcher GmbH
Hoya Corporation
Glaukos Corporation
Second Sight
Allergan

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.